Our Technology

We are focused on applying our novel technologies to support partner development efforts for their own proprietary programs and compounds.

Dry Powder Delivery: Technosphere^® Technology:
We have evaluated this versatile pulmonary drug delivery platform across multiple therapeutic areas, including diabetes, metabolism, osteoporosis and pain.
For companies interested in exploring the feasibility of a Technosphere formulation using their own active pharmaceutical ingredient (API), MannKind is able to prepare and characterize API/Technosphere formulations utilizing relevant PK/PD models, thereby providing a low risk non-clinical proof of principle, often within 6 months.
Inhalers: Device Technology: We have created an innovative line of patient-focused, breath-powered dry powder inhalers offering both high performance and cost-effectiveness.
Inhalation Profiling: BLUHALE^® is a wireless microphone-based technology adapted onto MannKind's dry powder delivery systems to characterize patient inhalation.

We are proud of our focus on innovative approaches to addressing unmet medical needs.

See how the Dreamboat inhaler works.